News

Premama earns 2016 NEXTY Award

BY Michael Johnsen
PROVIDENCE, R.I. – Premama has been named one of 19 winners of the New Hope Network 2016 NEXTY Awards for outstanding new products in the natural products industry. Premama Fertility reproductive support powdered supplement was honored as “Best New Supplement Delivery Format.” 
 
“Winning a NEXTY Award truly validates Premama’s effort to set new standards for maternity wellness,” stated Jamie Schapiro, chief marketing officer, Premama. “Premama Fertility reproductive support powdered supplement and all of our powdered drink mix and soft chew innovations are designed to offer women natural, palatable and effective solutions throughout the maternity journey and beyond.” 
 
“These 19 products represent the future of the natural products industry where sustainability and transparency are the norm,” commented Jessie Shafer, content director at New Hope Network and one of the NEXTY judges. “Our industry can have a huge influence on how big manufacturers and mainstream buyers think about consumer packaged goods. The winners of our NEXTY awards inspire change and integrity in everything from ingredients to packaging.”
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Mumsie introduces new, natural facial care products

BY Gina Acosta

NEEDHAM, MASS. — A skin care brand designed specifically for the needs of pre- and post-partum women is launching a new line of facial products.

Mumsie is unveiling two new additions this spring to its popular skin care family: a daily facial moisturizer with mineral sunscreen and a lifting & firming night cream with natural CoQ10. Both products are formulated safe and effective for pregnancy, breastfeeding, and for the years of sleepless nights after a child is born. All of the items in the Mumsie range are cosmeceutical grade.

“We’re just shocked that any consumer would use a chemical sunscreen nowadays with all of the data out there highlighting the various dangers associated with them,’ says Jamie Leventhal, executive vice president at Clio, “but we’re even more concerned to see pregnant or breastfeeding women using them as well.” Several clinical studies of oxybenzone, avobenzone and other chemical sunscreens, showed direct links to their use and low birth weights in babies, cancer, hormone disruption, mimicking the effects of estrogen and triggering developmental abnormalities, and free radical damage, amongst several other risks.

The Mumsie daily facial moisturizer with SPF 15 uses a non-nanoparticle titanium dioxide (deemed the safest sunscreen active ingredient on the market today) and several other natural and organic ingredients to soothe and hydrate the skin while improving the appearance of uneven skin tone, blemish marks and roughness often associated with the various phases of pregnancy.

CoQ10, a natural fuel for cellular energy that boosts skin repair and regeneration and reduces free radical damage, is uniquely infused into the Mumsie lifting & firming night cream. 

These two new products join the Mumsie lineup that includes a leading stretch mark relief oil, stretch mark relief cream and gentle facial cleanser – all 100% natural, 70% organic and void of harmful or irritating chemicals, parabens, sulfates, phthalates and dyes.

The entire Mumsie range will be available nationwide beginning in April at all Target stores and at several other major retailers in North America.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Mylan launches generic extended-release Ultram

BY David Salazar
PITTSBURGH — Mylan on Tuesday announced the launch of its generic of Ultram (tramadol hydrochloride) extended-release tablets in the United States. The drug is indicated to treat moderate to moderately sever chronic pain who require constant treatment for extended time periods. 
 
Mylan’s generic will be available in 100-, 200- and 300-mg dosage strength. The drug had annual U.S. sales of about $52.8 million for the 12 months ended Dec. 31, 2015, according to IMS Health. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?